Cite
A controlled clinical trial comparing potent progestins, LNG‐IUS and dienogest, for the treatment of women with adenomyosis
MLA
Hiroki Nagata, et al. “A Controlled Clinical Trial Comparing Potent Progestins, LNG‐IUS and Dienogest, for the Treatment of Women with Adenomyosis.” Reproductive Medicine and Biology, vol. 20, Sept. 2021, pp. 427–34. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26adf2b06200c8a86b7db983ea313419&authtype=sso&custid=ns315887.
APA
Hiroki Nagata, Tasuku Harada, Ikumi Wada, Fuminori Taniguchi, Ai Ikebuchi, Yukihiro Azuma, Eri Sato, Takaya Nakaso, Ikuko Ota, & Yoshiaki Ota. (2021). A controlled clinical trial comparing potent progestins, LNG‐IUS and dienogest, for the treatment of women with adenomyosis. Reproductive Medicine and Biology, 20, 427–434.
Chicago
Hiroki Nagata, Tasuku Harada, Ikumi Wada, Fuminori Taniguchi, Ai Ikebuchi, Yukihiro Azuma, Eri Sato, Takaya Nakaso, Ikuko Ota, and Yoshiaki Ota. 2021. “A Controlled Clinical Trial Comparing Potent Progestins, LNG‐IUS and Dienogest, for the Treatment of Women with Adenomyosis.” Reproductive Medicine and Biology 20 (September): 427–34. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26adf2b06200c8a86b7db983ea313419&authtype=sso&custid=ns315887.